Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK

INTRODUCTION: International guidelines recommend treatment with a sodium-glucose cotransporter-2 (SGLT-2) inhibitor or glucagon-like peptide-1 (GLP-1) receptor agonist for treatment intensification in type 2 diabetes mellitus (T2DM) patients with progression on metformin. In the randomised, controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Mafalda, Cummings, Michael H., Ustyugova, Anastasia, Raza, Syed I., de Silva, Shamika U., Lamotte, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434815/
https://www.ncbi.nlm.nih.gov/pubmed/32700188
http://dx.doi.org/10.1007/s13300-020-00883-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434815/
https://www.ncbi.nlm.nih.gov/pubmed/32700188
http://dx.doi.org/10.1007/s13300-020-00883-1

Ejemplares similares